4 Life Science Trends To Pay Attention To in 2021
XTalks
JANUARY 5, 2021
Developed by Ellume Therapeutics , the test is a rapid, lateral flow antigen test, which involves passing a liquid sample along a surface with detection antibodies. The test identifies SARS-CoV-2 protein fragments from nasal swab samples. The burden of clinical trials is on all patient groups and patient segments.
98 
Let's personalize your content